Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. (2020)
Attributed to:
MRC Centre for Genomics and Global Health
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(20)30552-3
PubMed Identifier: 32171078
Publication URI: http://europepmc.org/abstract/MED/32171078
Type: Journal Article/Review
Volume: 395
Parent Publication: Lancet (London, England)
Issue: 10233
ISSN: 0140-6736